Sareum (SAR) Competitors GBX 18.60 -0.30 (-1.59%) As of 07/25/2025 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock SAR vs. CHI, IGR, PHD, FEN, NMT, CGO, TSI, MYN, IDE, and EVGShould you be buying Sareum stock or one of its competitors? The main competitors of Sareum include CT UK High Income Trust (CHI), IG Design Group (IGR), Proactis (PHD), Frenkel Topping Group (FEN), Neometals (NMT), Contango (CGO), Two Shields Investments Plc (TSI.L) (TSI), Mayan Energy (MYN), IDE Group (IDE), and Evgen Pharma (EVG). These companies are all part of the "financial services" industry. Sareum vs. Its Competitors CT UK High Income Trust IG Design Group Proactis Frenkel Topping Group Neometals Contango Two Shields Investments Plc (TSI.L) Mayan Energy IDE Group Evgen Pharma Sareum (LON:SAR) and CT UK High Income Trust (LON:CHI) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings. Which has more risk & volatility, SAR or CHI? Sareum has a beta of -1.08, suggesting that its share price is 208% less volatile than the S&P 500. Comparatively, CT UK High Income Trust has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Which has stronger valuation and earnings, SAR or CHI? CT UK High Income Trust has higher revenue and earnings than Sareum. Sareum is trading at a lower price-to-earnings ratio than CT UK High Income Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSareumN/AN/A-£5.28M-£4.22-4.40CT UK High Income Trust£13.28M6.34£11.22M£0.101,010.00 Is SAR or CHI more profitable? CT UK High Income Trust has a net margin of 84.52% compared to Sareum's net margin of 0.00%. CT UK High Income Trust's return on equity of 10.59% beat Sareum's return on equity.Company Net Margins Return on Equity Return on Assets SareumN/A -270.25% -113.80% CT UK High Income Trust 84.52%10.59%6.32% Do insiders & institutionals believe in SAR or CHI? 51.6% of CT UK High Income Trust shares are owned by institutional investors. 5.0% of Sareum shares are owned by company insiders. Comparatively, 23.4% of CT UK High Income Trust shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media favor SAR or CHI? In the previous week, CT UK High Income Trust had 2 more articles in the media than Sareum. MarketBeat recorded 2 mentions for CT UK High Income Trust and 0 mentions for Sareum. CT UK High Income Trust's average media sentiment score of 1.94 beat Sareum's score of 0.00 indicating that CT UK High Income Trust is being referred to more favorably in the news media. Company Overall Sentiment Sareum Neutral CT UK High Income Trust Very Positive SummaryCT UK High Income Trust beats Sareum on 12 of the 12 factors compared between the two stocks. Get Sareum News Delivered to You Automatically Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SAR vs. The Competition Export to ExcelMetricSareumBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£23.24M£136.79M£5.70B£3.02BDividend Yield1.10%3.74%4.60%5.02%P/E Ratio-4.403.7528.10160.62Price / SalesN/A4,471.55429.37278,114.25Price / Cash11.3213.1936.2227.97Price / Book7.1342.328.664.69Net Income-£5.28M-£90.99M£3.25B£5.90B7 Day Performance1.69%4.83%4.22%0.31%1 Month Performance28.81%8.36%10.51%7.00%1 Year Performance-40.38%195.89%34.40%73.11% Sareum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SARSareumN/AGBX 18.60-1.6%N/A-41.9%£23.24MN/A-4.403,211Gap DownCHICT UK High Income TrustN/AGBX 102-2.9%N/A+11.6%£84.99M£13.28M1,020.00N/ANews CoverageDividend AnnouncementInsider TradeGap DownIGRIG Design GroupN/AGBX 74.50-0.7%GBX 270+262.4%-63.4%£73.11M£655.48M2.533,092PHDProactisN/AN/AN/AN/A£70.69M£48.90M-3.57516FENFrenkel Topping GroupN/AGBX 47.90+1.9%N/A+11.1%£58.68M£34.56M55.81307NMTNeometalsN/AN/AN/AN/A£57.39MN/A-1.87N/ACGOContangoN/AGBX 1+2.6%N/A-14.1%£7.23MN/A-100.002,219Gap UpTSITwo Shields Investments Plc (TSI.L)N/AN/AN/AN/A£6.15MN/A-1.053MYNMayan EnergyN/AN/AN/AN/A£5.28M-£3K-0.235Gap UpIDEIDE GroupN/AN/AN/AN/A£3.60M£13.64M-18.13237EVGEvgen PharmaN/AN/AN/AN/A£3.42MN/A-80.0010 Related Companies and Tools Related Companies CT UK High Income Trust Competitors IG Design Group Competitors Proactis Competitors Frenkel Topping Group Competitors Neometals Competitors Contango Competitors Two Shields Investments Plc (TSI.L) Competitors Mayan Energy Competitors IDE Group Competitors Evgen Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SAR) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredStrait of Hormuz = $100 Oil?Dow Drops 540 Points, Oil Soars Middle East conflict sends markets plunging, oil jumping 8.5%. Investors fl...The Oxford Club | SponsoredThe AI Chip Trade is OUT. This is in…Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sareum Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Sareum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.